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1. Introduction 
A class of calcium-activated proteases has been 
found in a wide variety of tissues (reviews [ 1,2]). In 
vertebrate [3-71 and invertebrate [8,9] nerves, 
similar type of proteolytic activity has been detected 
in the soluble compartment, acting preferentially on 
the neurofilament proteins. As neurofilaments are 
the major structural elements of the axoplasm, signif- 
icant roles for this enzyme in pathological [3-51 and 
developmental [6] aspects have been suggested. 
in addition. The homogenate was stirred at room tem- 
perature for 1 h, which was effective in increasing the 
yield of neurofilaments. The homogenate was then 
layered on TKM buffer containing 1 M sucrose, and 
centrifuged at 78 000 X g for 2 h. The neurofilament- 
enriched pellet from three animals was usually 
suspended in 10 ml TKM buffer. It was either assayed 
immediately for the proteolytic activity or stored at 
-80°C. 
2.2. Pro tease assay 
Here we report the presence of a calcium-activated 
protease associated with the cytoskeletal preparation 
of the mammalian spinal cord. This enzyme has 
lo-times higher calcium sensitivity compared to those 
reported in the nerve, and shows a very narrow sub- 
strate specificity directed towards 1 of the 3 major 
polypeptides of the mammalian neurofilaments, the 
160 000 MI polypeptide. Furthermore, a soluble 
inhibitory factor for this enzyme was found in the 
same tissue, suggesting a possible involvement of this 
enzyme-inhibitor system in the regulation of neuro- 
filament organisation. 
2. Materials aud methods 
2 .l . Cytoskeletal preparation from the spinal cord 
Neurofilament-enriched cytoskeletal material was 
prepared from rat spinal cords as in [lo] with a slight 
modification: Spinal cords from adult rats were 
homogenised in TKM buffer (50 mM Tris (pH 7.6), 
25 mM KU, 10 mM MgCl?) containing 1% Triton 
X-100,5 mM EGTA and 5 mM fi-mercapthoethanol 
Proteolytic activity was assessed by gel electro- 
phoresis on SDS slab gels as breakdown of polypep- 
tides. Standard incubation mixture contained (final 
vol., 1 ml); 0.5 ml 20 n-&l Tris (pH 7.6) containing 
5 mM /I-mercaptoethanol, 0.1 ml 50 mM Cat& (final 
cont. 5 mM), 0.2 ml 0.1 M cystelne, and 0.2 ml cyto- 
skeletal preparation suspended in TKM buffer. After 
incubation at 37°C for 30 min, the reaction was ter- 
minated by the addition of 0.2 ml of ice-cold 70% 
trichloroacetic acid. The trichloroacetic acid-insoluble 
material was collected by centrifugation, washed suc- 
cessively with ethanol, ethanol-ether (1: 1) and ether, 
dried, and finally dissolved in SDS sample buffer con- 
taining 2% SDS, 10% glycerol, 5 mM P-mercapto- 
ethanol and 80 mM Tris (pH 6.8). Aliquots were sub- 
jected to SDS gel electrophoresis as in [ 111, and 
stained with Coomassie brilliant blue R-250. 
2.3. fieparation of the inhibitory factor 
Fresh spinal cords were homogenised in 20 mM 
Tris (pH 7.6) containing 5 mM fi-mercaptoethanol 
and 5 mM EGTA, and centrifuged at 100 000 X g for 
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1 h. The supernatant was applied onto a column of 
DEAE-cellulose (Whatman DE-52), washed extensively 
with the same buffer and eluted with a linear [NaCl] 
gradient of O-O.5 M in the same buffer. Inhibitory 
activity was assayed by including 0.5 ml of the gradi- 
ent fraction in the standard incubation mixture in 
place of the buffer and raising CaCls to 10 mM. 
3. Results 
3.1. Proteoiy tic activity associated with the cytoskeletal 
preparation of the spinal cord 
The Triton-insoluble cytoskeletal preparation of 
the spinal cord is composed mainly of the neurofila- 
ment triplet (200, 160 and 68 X lo3 M,), glial fibril- 
lary acidic protein (GFA protein, 5 1 000 Mr [ 12]), 
actin (43 000 Mr) (iig.la). Incubation of this prepara- 
tion in the presence of mM levels of calcium revealed 
a proteolytic activity associated with this fraction 
(fig.lb). The 160 OOOM, polypeptide of the neuro- 
filament triplet was degraded preferentially, followed 
by a partial loss of the 68 000 Mr component. GFA 
protein and actin remain intact after 30 min at 37’C. 
a b cdefsh 
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Fig.1. Calciumdependent breakdown of the 160 000 Mr 
polypeptide in the cytoskeletal preparation of the spinal 
cord. T&on-extracted cytoskeletal preparation from the 
spinal cord was incubated for 30 min at 37°C in the presence 
of different concentrations of calcium. After incubation, 
trichloroacetic acid-insoluble material was recovered and 
analysed by SDS gel electrophoresis on 10% acrylamlde gels: 
(a) cytoskeletal preparation without incubation; (b-h) cyto- 
skeletal preparation incubated with (b) 5 mM CaCl,, (c) 
10 mM EGTA, (d) no addition, (e) 0.1 mM CaCI,, (f) 0.5 mM 
CaCl,, (g) 1 mM CaCl,, (h) 5 mM CaCl,. 200 K, 160 K and 
68 K are the 3 major polypeptides of the neurofdaments 
(K = x 10s3 Mr): (0) GFA protein; (4) actin. 
The enzyme activity was already detectable at 
0.1 mM Ca2+ (fig.le), reaching full activity at 0.2 mM 
Ca2+ (fig.lc-h). It was strictly dependent on Ca2+, as 
Mg2+ and Mn2+ could not replace Ca2+. 
Breakdown of the 160 000 Mr component was 
complete within 5 min (fig.2). The other two com- 
ponents of the neurofilaments were more resistant 
a: 
b: 
Fig.2. Densitometric tracings of the Coomassie-stained gel 
showing progressive breakdown of the neurofilament pro- 
teins during incubation with 5 mM CaCl,. Cytoskeletal pre- 
paration was incubated at 37°C in the standard medium con- 
taining 5 mM CaCl, for time periods. Trichloroacetic acid- 
insoluble material recovered after incubation was electro- 
phoresed on a SDS gel 10% in acrylamide. Incubation times 
were: (a) 0; (b) 5 mitt;(c) 30 mm;(d) 16 h. Three major 
polypeptides of the neurofiaments are marked with 200 K, 
160 K and 68 K (X lOWa AZ,): (a) GFA protein; (i) actin. 
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to this protease and were degraded only upon much 
longer incubations (16 h; fig2d). The GFA protein 
was remarkably stable even after prolonged incuba- 
tion, showing that the nzyme had a very narrow sub- 
strate specificity. 
The pH optimum for the proteolytic breakdown 
was between pH 7-8. The activity was effectively 
inhibited by 1 mM leupeptin, an oligopeptide inhibitor 
of some proteases uch as papain, cathepsin B, trypsin 
and the squid neurofilament protease [9]. 
The proteolytic activity could be separated from 
the cytoskeletal proteins by further extraction with 
0.6 M KCl. 
3.2. Soluble inhibitory factor of the cytoskeleton- 
associated protease 
Incubation of the whole spinal cord homogenate 
under similar conditions in the presence of 5 mM 
Ca2+did not lead to clear and reproducible breakdown 
of the proteins as with the cytoskeletal preparation. 
This suggested a possible occurrence of an inhibitory 
factor which might have been dissociated from the 
protease in the course of Triton extraction. 
Soluble supernatant of the spinal cord homogenate 
was applied onto a column of DEAE-cellulose, and 
Fig.3. Detection of a soluble inhibitory factor for the cyto- 
skeletonassociated protease. Soluble fraction of the spinal 
cord homogenate was applied onto a column of DEAE-cellu- 
lose and eluted with a linear [NaCl] gradient. Fractions were 
tested for their effects on the protease by including them in 
the assay mixture. After incubation at 3’7°C for 30 min, 
trichloroacetic acid-insoluble material was recovered and 
analysed by SDS gel electrophoresis. Number on top of 
each column denotes [NaCl] in mM of that fraction: (ft) 
flow-through fraction; GFA protein; &.) actin. The 3 neu- 
rofilament components are marked by 200 K, 160 K and 68 K 
(x10-J M,). 
the fractions eluted with a linear salt gradient were 
tested for their effects on the cytoskeleton-associated 
protease activity. Material eluted over 25-110 mM 
NaCl completely inhibited the breakdown of the 
160 000 Mr polypeptide (fig.3). This inhibitory factor 
was non-dialysable and heat-stable. 
4. Discussion 
Although the proteases dependent on mM levels 
of calcium have been reported in various tissues [ 1,2], 
the high calcium concentration required was a major 
problem in understanding the physiological signifi- 
cance of this type of enzymes. However, another type 
of calcium-activated protease with lo-times higher 
calcium sensitivity was found in cardiac muscle [ 131. 
Further studies revealed that the two types of pro- 
teases with different calcium requirements coexist in 
a wide variety of tissues at varying ratios [ 11. Generic 
names have been proposed for these two enzymes; 
‘calpain I’ for the enzyme which is fully activated with 
0.1 mM calcium; and ‘calpain 11’ for the other which 
requires 4-5 mM calcium [ 11. From the properties of 
the proteolytic activity described here, the cytoskele- 
ton-associated enzyme seems to be classified as 
calpain I. 
In the soluble compartment of the invertebrate 
and vertebrate nerves, calpain-type enzyme activities 
have been reported which selectively degrade the 
neurofilaments [3-91. However, in all cases the cal- 
cium level required for activity was >l mM. Thus 
those enzymes are probably of the calpain II-type. 
Substrate specificities reported for the mammalian 
enzymes were broader as well, compared to this 
enzyme described here. The protease in [3-S] 
degrades all 3 polypeptides of the neurofilament 
triplet, and that in the brain acts on actomyosin and 
tubulin as well as the neurofilaments [7]. The prote- 
ase reported here is specific towards the 160 000 M, 
component of the neurofilament triplet, being much 
less active towards the other 2 components and virtu- 
ally inactive towards the coexisting actin and the glial 
filament protein. The enzyme seems also to be more 
potent than those reported, as much less time was 
required to detect the activity. This may be a conse- 
quence of direct structural association between the 
enzyme and the substrate. 
This is the first report concerning the endogenous 
inhibitor of the neurotilament degrading enzyme. In 
43 
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other tissues, endogenous high J4r inhibitors of cal- 
pains, ‘calpastatins’, have been found [ 11. Experi- 
ments are in progress to purify the inhibitory factor 
from the spinal cord for further characterisation and 
comparison of its properties with the other ‘calpasta- 
tins’. 
From immunocytochemical studies using anti- 
bodies against each of the triplet proteins, it was con- 
cluded that the 68 OOOM, component makes up the 
core structure of the neurofilament, while 160 000 
and 200 000 Mr components are located peripherally 
[ 141. Presence of an enzyme specific towards one of 
the outer components suggests interesting possibilities 
that such a selective proteolysis may be involved in 
the control of filament-filament interaction. 
In [ 151, a calcium-activated protease specific for 
vimentin, another type of intermediate-sized silament 
protein, was associated with the cytoskeleton of 
Ehrlich ascites tumor cells. This enzyme was inactive 
towards other types of intermediate-sized filament 
proteins such as neurofilament proteins and GFA pro- 
tein. With this observation, controlled proteolysis by 
tissue specific proteases may be an important general 
mechanism for the regulation of intermediate-sized 
filament organisation in the cell. 
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